Search form

Sections

Valley fever cases skyrocketing, says CDC

Fellowship Story Showcase

Valley fever cases skyrocketing, says CDC

ABOUT THIS SERIES

In an occasional series that continues today, the Reporting on Health Collaborative is exploring the rise of cases, the tricky science of studying the disease, the high costs to patients and taxpayers, the lack of private interest in funding treatments and vaccines, and the long history of inaction by government agencies.

View the CDC study online at www.cdc.gov/mmwr.

Lab assistant Erin Scott with the Kern County Public Health Services Department places valley fever patient samples into test trays. Photo: Casey Christie / The Californian
Lab assistant Erin Scott with the Kern County Public Health Services Department places valley fever patient samples into test trays. Photo: Casey Christie / The Californian
Saturday, March 30, 2013

BY RACHEL COOK

Reporting on Health Collaborative

rcook [at] bakersfield [dot] com

 

The Centers for Disease Control and Prevention confirms in a new research article today what doctors, epidemiologists and people who suffer from valley fever have experienced first-hand — cases of the fungal disease rose at stunning rates over the last decade, especially in California and Arizona.

The CDC’s analysis addresses the findings reported in Just One Breath, a series of news stories on valley fever by the Reporting on Health Collaborative published in The Californian and other outlets. The series chronicled the rise in valley fever cases and deaths and the lack of attention by state and federal policymakers.

“I do think that the reporting series helped to put (valley fever) at the forefront, especially in California,” said Dr. Benjamin Park, medical officer in the CDC’s Mycotic Diseases Branch and the study’s senior author.

People catch coccidioidomycosis, also known as valley fever, after inhaling fungal spores that are common in the dry parts of the Southwest as well as Mexico and Latin America. Experts say the lack of funding and serious attention to valley fever has stalled efforts to combat the disease.

But valley fever seems to be gaining policy attention. House Majority Whip Kevin McCarthy, R-Bakersfield, and CDC Director Dr. Tom Frieden recently met to talk about valley fever’s impact in the Southwest.

"We discussed the possibility of developing a vaccine and also developing various strategies to combat this disease through better diagnosis, treatment and prevention, and I commend Dr. Frieden's willingness to accept the invitation I made for CDC officials to come to Bakersfield to improve awareness and meet with our local valley fever experts and our medical community,” McCarthy wrote in an

 Casey Christie / The Californian
email.

In an email, Frieden wrote that his agency is “committed to continuing to work together to address this serious and costly disease.”

Frieden also wrote that he is looking forward to welcoming McCarthy on a visit to the CDC in April to meet with the agency’s valley fever experts and tour facilities.

To better understand valley fever’s toll, the CDC analyzed data from the National Notifiable Diseases Surveillance System for the years from 1998 to 2011.

“What was surprising to me was that these increases (in valley fever) have been very consistent year over year,” Park said. “Overall, the trend, I think, is quite striking and it clearly shows that there is an increasing burden.”

The findings, published Thursday on the CDC’s Morbidity and Mortality Weekly Report, mirror much of what the Reporting on Health Collaborative found, including:

• The total number of valley fever cases rose by more than 850 percent in the area where valley fever is most common — California, Arizona, Nevada, New Mexico and Utah — from 1998 to 2011 to 22,401 cases. In California, the case counts rose from 719 in 1998 to 5,697 in 2011.

Cases in Arizona increased from 1,474 in 1998 to 16,467 in 2011. The study noted that a change in a major Arizona lab’s reporting practices could account for part of Arizona’s increase.

In states where the disease is not as common, the number of valley fever cases reported jumped from six in 1998 to 240 in 2011.

• For the entire period, a total of 111,717 coccidioidomycosis cases were reported to the CDC from 28 states and the District of Columbia. The CDC found that 66 percent were reported from Arizona and 31 percent were from California.

• Because cases can go up simply as a matter of the population increasing, the CDC also tracks the rate of the disease in the population — known as the incidence. The incidence of reported valley fever grew eight-fold from 1998 to 2011, rising from 5.3 per 100,000 people in the areas where valley fever is common to 42.6 per 100,000, the article said.

• The rise of valley fever occurred across all age groups. The rate of the disease was highest among 40- to 59-year-olds in California, but in other states the incidence was higher among people 60 and older.

 Casey Christie / The Californian
Terry Oubsuntia, microbiology specialist, labels valley fever test trays at the Kern County Public Health Services Department.
The study includes several caveats about its findings, noting that artificial increases in cases could be spurred by changes in how states monitor the disease and increases in the number of people being tested for valley fever. But the CDC research paper also points out that a 2006 study found only 2 to 13 percent of patients with signs and symptoms were tested for valley fever, indicating that the disease is likely greatly underreported.

“The problem is we don't really know what the underreporting rate is, but it's substantial,” said Dr. Royce H. Johnson, professor of medicine at UCLA and chief of infectious disease at Kern Medical Center.

Michael Lancaster, director of laboratory services at the Kern County Public Health Services Department, said the various factors mentioned in the article could add up to a bit of an increase but that “we're probably in reality seeing more valley fever.”

The study also notes a lack of data about race and ethnicity. Higher valley fever rates have been shown among blacks and Asians, and blacks are at greater risk for developing the most serious form of the disease, the study says. But the study says that about 70 percent of cases were missing details about race and ethnicity.

Valley fever experts said the numbers prove that the disease is a public health concern worthy of research dollars.

Better diagnostics, medications and a vaccine to fight the disease cannot be achieved without more money, they said.

Industry and government funding for valley fever research has dried up, Johnson said.

“There are many, many diseases getting more funding that are less important than this one,” Johnson said, noting the personal and financial cost of failing to address the growing problem of valley fever.

CDC’s Park said the study’s findings provide a strong argument for development of better treatments for valley fever so people suffering from the disease can resume their normal lives sooner and stay out of the hospital.

“Clearly more research is warranted and is needed,” he said.

Misdiagnosis is common when it comes to valley fever.

Doctors and public health officials stressed that educating physicians and the public generally to identify valley fever symptoms remains crucial because the disease is difficult to prevent.

“Because fungus particles spread through the air, it's nearly impossible to completely avoid exposure to this fungus in these hardest-hit states,” Frieden wrote. “It's important that people be aware of valley fever if they live in or have traveled to the southwest United States." 

Clarisse Tsang, acting infectious disease epidemiology program manager for the Arizona Department of Health Services and an author of the CDC study, said people should learn valley fever symptoms and ask their doctors to test them for the disease if they are suffering from a cough, fever and fatigue.

Physician awareness matters beyond Arizona and California, experts said, so that doctors examine patients’ travel histories and recognize that valley fever is a possibility if patients have journeyed through endemic areas.

Valley fever will continue to be a public health issue as more people who have not been exposed to the disease travel to areas where the fungus is common, Lancaster said.

“It's going to become an even worse problem,” he said.

The Reporting on Health Collaborative involves The Californian, the Merced Sun-Star, Radio Bilingue in Fresno, The Record in Stockton, Valley Public Radio in Fresno and Bakersfield, Vida en el Valle in Fresno, the Voice of OC in Santa Ana and ReportingonHealth.org. It's an initiative of The California Endowment Health Journalism Fellowships at the University of Southern California's Annenberg School for Communication and Journalism.

You can also read the series at www.bakersfieldcalifornian.com/special-sections/just-one-breath.

 Photo Credits: Casey Christie / The Californian 

About This Series

This project results from a new venture – the Reporting On Health collaborative – which involves the Bakersfield Californian, the Merced Sun-Star, Radio Bilingüe in Fresno, The Record in Stockton, Valley Public Radio in Fresno and Bakersfield, Vida en el Valle in Fresno, the Voice of OC in Santa Ana and ReportingonHealth.org. The collaborative is an initiative of The California Endowment Health Journalism Fellowships at the University of Southern California’s Annenberg School for Communication and Journalism.

RELATED STORIES THIS WEEK

Public pushes for new thinking in valley fever research

Advocates of valley fever research have complained that the disease does not affect enough people to garner attention and funding; local doctors often misdiagnosed it; most data about the disease dates back decades; and the public has little knowledge of the disease and its impact.

Valley Fever Research Day Aims To Connect With Community

Community members are invited to attend Valley Fever Research Day Saturday at the UCSF Fresno Center for Medical Education and Research. The event is an opportunity for researchers to connect with community members who have been impacted by the fungal disease.

Federal, local officials hopeful for 'new era' in valley fever

Many questions about valley fever remained unanswered Tuesday as public health officials, physicians and politicians finished a two-day symposium on the disease, but many were hopeful that the summit will be a turning point.

Agencies to Launch Randomized Controlled Trial for Valley Fever

Directors of the National Institutes of Health and U.S. Centers for Disease Control and Prevention tell a packed valley fever symposium they are "serious" about finding a better treatment for the disease.

Just One Breath: Valley fever’s human and financial costs detailed in new study

The rate of people being hospitalized for valley fever has doubled in California over the past decade. Not only are more people being diagnosed with the disease but the cases are serious enough that more people are ending up in the hospital.

Valley Fever Symposium

On Monday, valley fever and the California area hit hardest by it will receive unprecedented attention in a two-day symposium led by U.S. Rep. Kevin McCarthy, R-Bakersfield. Rarely do the leaders of CDC and the NIH - two of the most powerful health institutions in the world - join the stage.

Just One Breath: Valley Fever Deserves More Ink in Scientific Journals

Valley fever hasn’t generated significant research funding. What will help move the needle? A sustained effort by public health advocates, clinicians and patients and their families and continued attention from media outlets.

Just One Breath: Valley fever movement could learn from health success stories

Strong patient advocacy raised the profile of breast cancer and HIV/AIDS. What lessons can those involved in the fight against valley fever learn from other, more high profile diseases?